HB 624 (Safe Staffing Act of 2026) requires most Maryland hospitals to establish clinical staffing committees with equal management and employee representation, including specific frontline staff like nursing assistants and dietary aides. These committees must develop annual staffing plans considering patient acuity, staffing gaps, and evidence-based standards, then post the plans publicly and update them yearly. Hospitals must implement these plans starting in 2028, allow staff to file complaints about violations, and report annually to the Maryland Health Care Commission beginning in 2030. The law directly affects licensed hospitals and frontline healthcare workers by mandating structured, transparent staffing processes to address patient care needs.
SB 439 prohibits Maryland fire and rescue public safety employers from taking negative employment actions (like firing or denying promotions) against employees who use medical cannabis, provided the employee has a valid medical cannabis certification under state law. It amends existing Maryland law to explicitly add this protection for public safety workers, aligning with current medical cannabis certification requirements. The bill does not change how medical cannabis is certified but ensures these employees cannot face discrimination solely for using cannabis legally under the state program. This applies to all fire and rescue employees who meet the state's medical cannabis eligibility criteria.
SB 336 extends the deadline for the existing Task Force on Responsible Use of Natural Psychedelic Substances, established by 2024 law, to continue its work studying natural psychedelic substances like psilocybin and mescaline (excluding peyote). The task force, composed of state officials, experts, and community representatives, will study current laws, scientific data on benefits and risks, and barriers to access, then make recommendations for a state access program and legal changes. This extension allows the task force to finalize its report on creating equitable access to these substances and transitioning away from criminal penalties for nonviolent uses. The bill does not change current laws but prolongs the study period to inform future policy decisions.
SB 449 extends workers' compensation benefits to Carroll County correctional deputies who develop heart disease or hypertension. It creates a legal presumption that these conditions are work-related (and thus compensable) if they result in partial disability or death, provided the condition is more severe than any pre-existing condition and the deputy had a medical exam before employment. The bill amends Maryland law to explicitly include "Carroll County Correctional Deputy" in the definition of "public safety employee" for these benefits. This change applies specifically to Carroll County deputies and requires meeting the severity and medical exam conditions to qualify.
HB 672 amends the Maryland Pediatric Cancer Fund to specify that only nonprofit hospitals, educational institutions, and other nonprofit organizations may receive grants for pediatric cancer research, removing previous eligibility for physicians, laboratories, and individuals. The bill requires grant funds to be used exclusively for direct research costs, prohibiting use for administrative overhead or community-based services. It also mandates annual reporting to the General Assembly on fund administration, promotional efforts, and detailed fund usage.
SB 910 requires Maryland health insurers to reimburse patients for services provided by graduate-level clinical interns in counseling, social work, and psychology, under specific conditions. This affects insured individuals who receive these services and insurers who must cover them. Key conditions include services being provided at outpatient facilities, interns being enrolled in accredited graduate programs, working under direct supervision of a licensed professional, and billed by the supervising provider. The bill amends existing insurance codes (Sections 15-704, 15-707, and 15-714) to add these reimbursement requirements for each profession’s interns.
This bill expands Maryland's child abuse reporting requirements by explicitly including female genital mutilation in the legal definition of abuse, which directly affects healthcare providers, educators, and other mandated reporters. It mandates that these professionals report suspected cases of female genital mutilation to authorities and increases penalties for violations while allowing individuals subjected to the procedure to file civil lawsuits for relief. The legislation also requires the Maryland Department of Health to create and distribute educational materials about female genital mutilation in partnership with various public and private organizations. Additionally, the bill authorizes health licensing boards to revoke licenses of individuals who commit violations related to female genital mutilation under specific circumstances.
SB 493 prohibits nursing facilities in Maryland from involuntarily discharging or transferring residents except for specific reasons like the resident's welfare, health improvement, or facility closure. It requires facilities to provide residents with a clear written notice at least 10 days before any involuntary discharge or transfer, detailing the reason, new location, and contact information for hearings and legal assistance. The bill also bans sending residents to temporary housing (like hotels) without confirmation from the receiving facility and prevents facilities from discharging Medicaid-eligible residents solely because they qualify for Medicaid. These changes aim to protect vulnerable residents by ensuring proper notice, preventing unfair treatment, and requiring confirmation before transfers.
SB 562 allows pharmacists in Maryland to treat opioid use disorders using medication therapy under specific conditions. It repeals a requirement that prescribers (like doctors) must submit agreements to their health board and instead authorizes pharmacists to enter into prescriber-pharmacist agreements if they meet qualifications such as holding a Doctor of Pharmacy degree, completing required training, and registering with federal agencies. The law mandates that any treatment protocol requires pharmacists to check the Prescription Drug Monitoring Program before starting or changing medication. This change aims to expand access to medication-based treatment for opioid use disorders by enabling pharmacists to provide care in pharmacy settings.
SB 24 revises Maryland's Public Access Automated External Defibrillator (AED) Program to improve oversight and accessibility. It requires most organizations using public AEDs to appoint an AED coordinator responsible for maintenance, reporting, and emergency notification, while exempting law enforcement agencies from needing certificates for AEDs in patrol vehicles. The bill also repeals outdated requirements for regional AED committees and clarifies that grocery stores and restaurants are not subject to certain AED registration rules. These changes aim to streamline compliance for entities managing public AEDs, including schools, businesses, and public facilities.
